Clinical Trial Update: Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) [Phase 4]

View source ↗

Summary

Phase 4 trial update on citicoline for non-arteritic anterior ischemic optic neuropathy (NAION) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Valen Chia | Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy | Phase 4 | Status: COMPLETED